and RP-HPLC and used for the cyclization step without further purification.
MS (ESI) m/z [M + H]
+ 801.4. RP-HPLC (Bondapak, 10 μm, 125 Å, 3.9 mm × 300 mm) run with linear gradients of ACN (0.1% TFA) into H 2 O (0.1% TFA) over 30 min, at a flow rate of 1.0 mL/min, with an UV detector set at 220 nm): t R : 12.2 min.; conditions: 5 → 100% acetonitrile in 30 minutes (A: 0.1% TFA in water, B: 0.1% TFA in acetonitrile), flow: 1.0 ml/min, 220 nm; purity > 90%.
To a stirred solution of HATU (220 mg, 0.58 mmol), DIPEA (116 mg, 0.90 mmol) in dry DMF (38 mL) at room temperature, a solution of linear precursor 35 (0.14 mmol) in dry DMF (10 mL) was added by syringe pump during 6 h. After 18 h the resulting mixture was concentrated in vacuo, diluted with DCM (20 mL) and washed with 1 M HCl (3 × 7 mL). The mixture was extracted with DCM (2 × 10 mL) and the combined organic phases were washed three times with water (10 mL), dried with MgSO 4 and concentrated in vacuo.
The crude residue was purified by reversed phase chromatography on C 18 bonded silica to afford 6. 
Synthesis of cyclopeptoid 7
Reagents and conditions: a) bromoacetic acid, DIPEA; b) PhNH 2 ; c) N-Fmoc-L-Proline, HATU; d) 20% piperidine/DMF; e) bromoacetic acid, DIC; f) HFIP/DCM (1:4). DIPEA = N,N diisopropylethylamine; DIC = N,N' -diisopropyl carbodiimide; g) HATU, DIPEA.
S4
Linear peptoid 36 was synthesized by alternating submonomer solid-phase method using standard manual Fmoc solid-phase peptide synthesis protocols. 0.20 g of 2-chlorotrityl chloride resin (Novabiochem; 2,α-dichlorobenzhydryl-polystyrene crosslinked with 1% DVB; 100-200 mesh; 1.63 mmol/g) was swelled in dry DCM (2 mL) for 45 min and washed twice in dry DCM (2 mL). Bromoacetic acid (72 mg, 0.52 mmol) and DIPEA (207 mg, 1.6 mmol) in dry DCM (2 mL) were added to the resin and the vessel was stirred on a shaker platform for 40 min at room temperature, and then washed with dry DCM (3 × 4 mL) and then with DMF (3 × 4 mL). Then benzylamine (349 mg, 3.26 mmol) in dry DMF (2 mL) was added to the bromoacetylated resin. The mixture was left on a shaker platform for 40 min at room temperature, then the resin was washed with DMF (3 × 2 mL), DCM (3 × 2 mL) and then with DMF (3 × 2 mL). The resin was incubated with a solution of N-Fmoc-L-proline (330 mg, 0.98 mmol), HATU (361 mg, 0.95 mmol) and DIPEA (168 mg, 1.30 mmol) in dry DMF (2 mL) on a shaker platform for 1 h, followed by extensive washes with DMF (3 × 2 mL), DCM (3 × 2 mL) and DMF (3 × 2 mL). Chloranil test was performed and once the coupling was complete the Fmoc group was deprotected by sequential additions of two aliquots of 20% piperidine/DMF (v/v, 2 mL), stirring on a shaker platform for 3 and 7 min respectively, followed by extensive washes with DMF (3 × 2 mL), DCM (3 × 2 mL) and DMF (3 × 2 mL). Subsequent bromoacetylation reactions were accomplished by reacting the oligomer with a solution of bromoacetic acid (453 mg, 3.26 mmol) and DIC (453 mg, 3.59 mmol) in DMF (2 mL), stirring on a shaker platform for 40 min at room temperature. Then, reaction with benzylamine, with N-Fmoc-L-proline, Fmoc deprotection and bromoacetylation steps were repeated twice as described above. Subsequently, a further sequence consisting of reaction with benzylamine, with NFmoc-L-proline and Fmoc deprotection was effected. The addition of the proline at the fourth, sixth and eighth positions required longer reaction time (3 h). The oligomer-resin was finally cleaved by treatment with three aliquots of a solution of 20% HFIP in DCM (v/v; 3 × 2 mL), with stirring each time on a shaker platform for 30 min at room temperature, and filtering the resin away after each treatment. The combined filtrates were concentrated in vacuo. The final product was analyzed by ESI mass spectrometry and RP-HPLC and used for the cyclization step without further purification.
MS (ESI) m/z [M + H]
+ 995.6. RP-HPLC (Bondapak, 10 μm, 125 Å, 3.9 mm × 300 mm) run with linear gradients of ACN (0.1% TFA) into H 2 O (0.1% TFA) over 30 min, at a flow rate of 1.0 mL/min, with an UV detector set at 220 nm): t R : 11.9 min; conditions: 5 → 100% acetonitrile in 30 minutes (A: 0.1% TFA in water, B: 0.1% TFA in acetonitrile), flow: 1.0 ml/min, 220 nm; purity > 90%.
The same cyclization procedure reported for compound 6 was followed for the synthesis of compound 7. 4 were synthetized as described in literature. Previously undescribed substrates 10, 11 and 21 were prepared as described below.
Synthesis of (S)-2-Phenyl-2-oxazoline-4-carboxylic acid cumyl ester (10)
To a solution of (S)-2-phenyl-2-oxazoline-4-carboxylic acid 5 (112 mg, 0.59 mmol) in dry DCM (2.5 mL) under nitrogen atmosphere was added 1-methyl-1-phenylethyl 2,2,2-trichloro acetimidate 6 (0.17 mg, 0.59 mmol). The reaction mixture was stirred for 65 h, diluted with DCM (2 mL), and centrifuged for two times. The recovered organic phase was concentrated in vacuo. The residue was purified by column chromatography (silica gel, petroleum ether−ethyl acetate: 100:0 to 98:2); to afford 10 (66 mg, 40% yield), as a white solid: mp = 117-120 °C. R f = 0. 
Synthesis of (S)-2-Phenyl-2-oxazoline-4-carboxylic acid benzhydryl ester (11)
To a solution of (S)-2-Phenyl-2-oxazoline-4-carboxylic acid (212 mg, 1.11 mmol) and benzophenone hydrazone 7 (327 mg, 1.67 mmol) in DCM (3.4 mL) was added a solution of iodine in DCM [0.15 mL, 1% (w/v)]. The mixture was cooled to -10 °C and PhI(OAc) 2 (536 mg, 1.66 mmol) was added portion wise over a period of 30 min. Then the reaction mixture was allowed to warm to room temperature and stirred for 22 h. The solvent was evaporated under reduced pressure and the residue was dissolved in EtOAc (20 mL). The organic phase was washed with H 2 O (1 x 10 mL), 5% NaHCO 3 -solution (3 x 10 mL), H 2 O (1 x 20 mL) and brine (1 x 10 mL), dried over Na 2 SO 4 
Synthesis of (S)-2-(4-Methoxyphenyl)-2-oxazoline-4-carboxylic acid tert-butyl ester (21)
The synthetic strategy was the same described in experimental section for compound 20, starting from a solution of 4-methoxybenzoic acid to afford (S)-2-((4-methoxybenzoyl)-amino))-3-hydroxypropionic acid tert-butyl ester (198.5 mg, 66% yield) as a yellow oil. This compound was used without further purification to afford 21 (134 mg, 72% yield) as a white solid: mp= 70-71 °C. R f = 0.35 (petroleum ether−ethyl acetate: 8:2). 
HRMS (MALDI) m/z

